Skip to main content
Century Therapeutics, Inc. logo

Century Therapeutics, Inc. — Investor Relations & Filings

Ticker · IPSC ISIN · US15673T1007 US Manufacturing
Open in API
Filings indexed 380 across all filing types
Latest filing 2026-06-08 Regulatory Filings
Country US United States of America
Listing US IPSC

About Century Therapeutics, Inc.

https://www.centurytx.com/

Century Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic cell therapies derived from induced pluripotent stem cells (iPSCs). The company's platform utilizes the self-renewing capacity of iPSCs, combined with advanced cellular engineering and manufacturing, to create 'off-the-shelf' natural killer (NK) and T cell product candidates. These therapies are being developed for the treatment of hematological malignancies, solid tumors, and autoimmune diseases. Century aims to overcome the limitations of existing cell therapies by designing products with enhanced functionalities that are intended to be more effective, tolerable, and accessible for patients.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 87% confidence The document is a U.S. SEC Form 8-K Current Report filed under Section 13/15(d) of the Exchange Act. It reports “Other Events” (Item 8.01) and lists exhibits (press release and conference slides). It does not contain earnings details, board changes, M&A activity, or full financial statements. This is a regulatory notice of events rather than a standalone financial report or presentation, so it falls into the general Regulatory Filings category (RNS).
2026-06-08 English
424B7
Capital/Financing Update Classification · 85% confidence The document is an SEC 424B7 prospectus supplement amending a previously filed prospectus to reflect changes in the selling stockholder table for a registered resale offering of common stock. This is part of a securities offering and not an earnings release, management discussion, or board change notice. It updates capital‐raising/disposition details and thus falls under Capital/Financing Update (CAP).
2026-05-21 English
8-K - Century Therapeutics, Inc. (0001850119) (Filer)
Report Publication Announcement Classification · 92% confidence The document is a Form 8-K current report (under Item 2.02 Results of Operations and Financial Condition) that simply furnishes a press release reporting quarterly results as Exhibit 99.1. It does not include substantive financial data itself but notes the report is attached. Under the “menu vs. meal” rule, this is an announcement of the report’s publication rather than the report itself. Therefore, this is a Report Publication Announcement (RPA).
2026-05-13 English
10-Q - Century Therapeutics, Inc. (0001850119) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
DEF 14A - Century Therapeutics, Inc. (0001850119) (Filer)
Proxy Solicitation & Information Statement
2026-04-27 English
4 Filing
Director's Dealing
2026-02-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.